![Matthew Greenhawt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 393 470 $ as of 2026-08-30
Mr. Matthew Greenhawt was previously employed as a Chief Medical Officer by Aquestive Therapeutics, Inc. and a Chief Medical Officer by Asthma & Allergy Foundation of America.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-08 | 77,000 ( 0.06% ) | 393 470 $ | 2026-08-30 |
| Companies | Position | End |
|---|---|---|
Asthma & Allergy Foundation of America
 Asthma & Allergy Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Chief Tech/Sci/R&D Officer | 2025-12-31 |
| AQUESTIVE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 2 |
|---|---|
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
Asthma & Allergy Foundation of America
Asthma & Allergy Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Select your edition
All financial news and data tailored to specific country editions
